DekaBank Deutsche Girozentrale
APLT

DekaBank Deutsche Girozentrale’s Applied Therapeutics APLT Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7,000
Closed -$150K – 1373
2021
Q2 		$150K Hold
7,000
– – ﹤0.01% 1277
2021
Q1 		$129K Hold
7,000
– – ﹤0.01% 1258
2020
Q4 		$151K Buy
+7,000
New +$146K ﹤0.01% 1222

Other funds holding APLT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

DekaBank Deutsche Girozentrale's APLT Position: Q3 2021 in Review

DekaBank Deutsche Girozentrale sold out of Applied Therapeutics (APLT) in Q3 2021, closing a stake of 7,000 shares — an estimated $150K sold.

DekaBank Deutsche Girozentrale first reported a position in APLT in Q4 2020 and held it in 3 quarters. The position peaked at $151K in Q4 2020. 70 funds tracked by Wall St. Rank hold APLT as of Q3 2021.

  • DekaBank Deutsche Girozentrale reported no remaining Applied Therapeutics position as of Q3 2021 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 7,000 Applied Therapeutics shares in Q3 2021, an estimated $150K.
  • DekaBank Deutsche Girozentrale first reported a position in Applied Therapeutics in Q4 2020 and held it in 3 quarters.
  • DekaBank Deutsche Girozentrale's Applied Therapeutics position peaked at $151K in Q4 2020.
  • 70 funds tracked by Wall St. Rank held Applied Therapeutics as of Q3 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2021, filed 22 Oct 2021.